Norris Medicines informs about disclosure of material impact of covid-19

01 Jun 2020 Evaluate

Pursuant to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, Norris Medicines has informed that it has enclosed the disclosure on material impact of COVID-19 pandemic on the Company.

The above information is a part of company’s filings submitted to BSE.


Norris Medicines Share Price

12.75 -0.92 (-6.73%)
02-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.90
Dr. Reddys Lab 1182.35
Cipla 1311.75
Zydus Lifesciences 879.25
Lupin 2128.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×